MARKET REPORT: Taking Stock
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Beaufort, a business services group, rose 1.25p to 4.25p after posting more than doubled profits of pounds 504,000. well ahead of subdued expectations. There are hopes it will nudge pounds 1m this year. The group, which embraces a consultancy managing and marketing sponsorships, arrived in November at 3p. Then there was talk of profits at pounds 650,000. Beaufort is casting around for acquisitions and is talking to six companies.
Proteus International, the drug group, has appointed Panmure Gordon as joint stockbroker with Teather & Greenwood. The shares rose 2p to 50p.
John Lusty, the food group suspended at 8.5p in March, should return to market later this month. It is paying pounds 3m in cash and shares for Ryne Quality Confectionery.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments